Emergence of resistant Streptococcus pneumoniae: A problem in pediatrics

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Penicillin resistance among strains of Streptococcus pneumoniae has emerged as an important worldwide problem. Beta-lactam-resistant pneumococci also can be resistant to erythromycin, trimethoprim/sulfamethoxazole and tetracycline and are uniformly susceptible to vancomycin and imipenem. Crowded conditions (e.g. day-care centers, hospitals, military barracks and prisons) and prior beta-lactam antibiotic therapy are the principal predisposing factors to colonization and disease. To date the two conditions caused by penicillin- and cephalosporin-resistant pneumococci that have been especially difficult to treat are acute otitis media and meningitis. Concentrations of beta-lactams in cerebrospinal fluid and middle ear fluid are usually inadequate to achieve prompt eradication of some intermediately resistant and most highly resistant pneumococcal strains. Use of unconventional therapeutic agents such as ceftriaxone or clindamycin for acute otitis media and vancomycin or rifampin for meningitis may be necessary. Control of this global problem will require innovative methods to reduce the selective pressure that results from widespread antibiotic use and to develop effective pneumococcal vaccines that are immunogenic in young infants.

Original languageEnglish (US)
Pages (from-to)424-428
Number of pages5
JournalPediatric Infectious Disease Journal
Volume14
Issue number5
StatePublished - 1995

Fingerprint

beta-Lactams
Streptococcus pneumoniae
Otitis Media
Vancomycin
Pediatrics
Meningitis
Anti-Bacterial Agents
Penicillin Resistance
Military Hospitals
Pneumococcal Vaccines
Clindamycin
Ceftriaxone
Imipenem
Prisons
Sulfamethoxazole Drug Combination Trimethoprim
Therapeutic Uses
Middle Ear
Erythromycin
Cephalosporins
Rifampin

Keywords

  • Acute otitis media
  • meningitis
  • resistance
  • Streptococcus pneumoniae

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pediatrics, Perinatology, and Child Health

Cite this

Emergence of resistant Streptococcus pneumoniae : A problem in pediatrics. / McCracken, G. H.

In: Pediatric Infectious Disease Journal, Vol. 14, No. 5, 1995, p. 424-428.

Research output: Contribution to journalArticle

@article{e3370da23d434e0abf871b0c07677b5b,
title = "Emergence of resistant Streptococcus pneumoniae: A problem in pediatrics",
abstract = "Penicillin resistance among strains of Streptococcus pneumoniae has emerged as an important worldwide problem. Beta-lactam-resistant pneumococci also can be resistant to erythromycin, trimethoprim/sulfamethoxazole and tetracycline and are uniformly susceptible to vancomycin and imipenem. Crowded conditions (e.g. day-care centers, hospitals, military barracks and prisons) and prior beta-lactam antibiotic therapy are the principal predisposing factors to colonization and disease. To date the two conditions caused by penicillin- and cephalosporin-resistant pneumococci that have been especially difficult to treat are acute otitis media and meningitis. Concentrations of beta-lactams in cerebrospinal fluid and middle ear fluid are usually inadequate to achieve prompt eradication of some intermediately resistant and most highly resistant pneumococcal strains. Use of unconventional therapeutic agents such as ceftriaxone or clindamycin for acute otitis media and vancomycin or rifampin for meningitis may be necessary. Control of this global problem will require innovative methods to reduce the selective pressure that results from widespread antibiotic use and to develop effective pneumococcal vaccines that are immunogenic in young infants.",
keywords = "Acute otitis media, meningitis, resistance, Streptococcus pneumoniae",
author = "McCracken, {G. H.}",
year = "1995",
language = "English (US)",
volume = "14",
pages = "424--428",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Emergence of resistant Streptococcus pneumoniae

T2 - A problem in pediatrics

AU - McCracken, G. H.

PY - 1995

Y1 - 1995

N2 - Penicillin resistance among strains of Streptococcus pneumoniae has emerged as an important worldwide problem. Beta-lactam-resistant pneumococci also can be resistant to erythromycin, trimethoprim/sulfamethoxazole and tetracycline and are uniformly susceptible to vancomycin and imipenem. Crowded conditions (e.g. day-care centers, hospitals, military barracks and prisons) and prior beta-lactam antibiotic therapy are the principal predisposing factors to colonization and disease. To date the two conditions caused by penicillin- and cephalosporin-resistant pneumococci that have been especially difficult to treat are acute otitis media and meningitis. Concentrations of beta-lactams in cerebrospinal fluid and middle ear fluid are usually inadequate to achieve prompt eradication of some intermediately resistant and most highly resistant pneumococcal strains. Use of unconventional therapeutic agents such as ceftriaxone or clindamycin for acute otitis media and vancomycin or rifampin for meningitis may be necessary. Control of this global problem will require innovative methods to reduce the selective pressure that results from widespread antibiotic use and to develop effective pneumococcal vaccines that are immunogenic in young infants.

AB - Penicillin resistance among strains of Streptococcus pneumoniae has emerged as an important worldwide problem. Beta-lactam-resistant pneumococci also can be resistant to erythromycin, trimethoprim/sulfamethoxazole and tetracycline and are uniformly susceptible to vancomycin and imipenem. Crowded conditions (e.g. day-care centers, hospitals, military barracks and prisons) and prior beta-lactam antibiotic therapy are the principal predisposing factors to colonization and disease. To date the two conditions caused by penicillin- and cephalosporin-resistant pneumococci that have been especially difficult to treat are acute otitis media and meningitis. Concentrations of beta-lactams in cerebrospinal fluid and middle ear fluid are usually inadequate to achieve prompt eradication of some intermediately resistant and most highly resistant pneumococcal strains. Use of unconventional therapeutic agents such as ceftriaxone or clindamycin for acute otitis media and vancomycin or rifampin for meningitis may be necessary. Control of this global problem will require innovative methods to reduce the selective pressure that results from widespread antibiotic use and to develop effective pneumococcal vaccines that are immunogenic in young infants.

KW - Acute otitis media

KW - meningitis

KW - resistance

KW - Streptococcus pneumoniae

UR - http://www.scopus.com/inward/record.url?scp=0029016836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029016836&partnerID=8YFLogxK

M3 - Article

C2 - 7638032

AN - SCOPUS:0029016836

VL - 14

SP - 424

EP - 428

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 5

ER -